Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Jellison swaps Dentsply for Stryker

This article was originally published in Clinica

Executive Summary

Stryker has found a new CFO – but its gain is dental implant maker Dentsply’s loss. William Jellison will join the Kalamazoo, Michigan-based orthopaedic firm on 22 April, replacing Dean Bergy, who has been filling the CFO role on an interim basis since October when Kevin Lobo was named CEO (www.clinica.co.uk, 2 October 2012). At the time, CFO Curt Hartman, who had been filling in as chief, announced plans to leave the company – many had believed Mr Hartman wanted the CEO role for himself. Mr Bergy will remain Stryker’s vice-president and corporate secretary. New CFO Mr Jellison has spent 15 years at Dentsply, and Stryker believes his “extensive experience and strong track record” will help it “drive globalisation and cost optimisation”. The company is already showing ambition in the former area, acquiring Chinese trauma and spine specialist Trauson for $764 million in a deal that closed in March (www.clinica.co.uk, 4 March 2013). Meanwhile, Dentsply has already appointed a new CFO: president and chief operating office Chris Clark, who has been with the company since 1993. Executive Jim Mosch will move into the COO role.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT100206

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel